Milestone Pharmaceuticals Inc. (MIST) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 238K | 1.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | -100% | -100% | -100% | - |
| Cost of Goods Sold | 70K | 0 | 25K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 29.41% | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 168K | 1.55M | -25K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 70.59% | 100% | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | -100% | -100% | -100% | - |
| Operating Expenses | 23.94M | 18.8M | 11.88M | 12.53M | 20.52M | 12.35M | 9.62M | 9.66M | 10.48M | 13.8M | 15.36M | 16.44M |
| OpEx % of Revenue | 10058.82% | 1216.24% | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 4.82M | 13.28M | 7.86M | 8.86M | 15.54M | 8.41M | 5.65M | 6.85M | 6.84M | 8.35M | 8.64M | 7.81M |
| SG&A % of Revenue | 2026.89% | 859.12% | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 3.36M | 5.52M | 4.01M | 3.67M | 4.98M | 3.94M | 3.96M | 2.81M | 3.64M | 5.45M | 6.72M | 8.62M |
| R&D % of Revenue | 1411.76% | 357.12% | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -23.77M | -17.26M | -11.9M | -12.53M | -20.52M | -12.35M | -9.62M | -9.66M | -10.48M | -13.8M | -15.36M | -16.44M |
| Operating Margin % | -9988.24% | -1116.24% | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -15.83% | -39.76% | -23.77% | -29.69% | -95.9% | 10.52% | 37.4% | 41.21% | 32.42% | -0.3% | -2.2% | 2.2% |
| EBITDA | -23.72M | -17.22M | -11.88M | -12.5M | -20.5M | -12.32M | -9.59M | -9.64M | -10.45M | -13.77M | -15.34M | -16.41M |
| EBITDA Margin % | -9964.71% | -1114.04% | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -15.71% | -39.77% | -23.83% | -29.75% | -96.17% | 10.54% | 37.46% | 41.29% | 32.52% | -0.22% | -2.22% | 2.2% |
| D&A (Non-Cash Add-back) | 56K | 34K | 25K | 28K | 27K | 26K | 25K | 26K | 28K | 26K | 24K | 24K |
| EBIT | -23.77M | -16.42M | -11.03M | -12.02M | -19.83M | -11.44M | -8.54M | -8.48M | -9.48M | -12.75M | -14.24M | -15.22M |
| Net Interest Income | -2.4M | -152K | -93K | -435K | -238K | -15K | 177K | 299K | 122K | 189K | 279K | 393K |
| Interest Income | 1.73M | 833K | 874K | 516K | 697K | 904K | 1.08M | 1.19M | 994K | 1.05M | 1.12M | 1.21M |
| Interest Expense | 4.13M | 985K | 967K | 951K | 935K | 919K | 903K | 887K | 872K | 857K | 841K | 820K |
| Other Income/Expense | -2.4M | -152K | -93K | -435K | -238K | -15K | 177K | 299K | 122K | 189K | 279K | 393K |
| Pretax Income | -26.18M | -17.41M | -11.99M | -12.97M | -20.76M | -12.36M | -9.44M | -9.36M | -10.35M | -13.61M | -15.08M | -16.04M |
| Pretax Margin % | -10997.9% | -1126.07% | - | - | - | - | - | - | - | - | - | - |
| Income Tax | -109K | 0 | -73K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0.42% | 0% | 0.61% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -26.07M | -17.41M | -11.92M | -12.97M | -20.76M | -12.36M | -9.44M | -9.36M | -10.35M | -13.61M | -15.08M | -16.04M |
| Net Margin % | -10952.1% | -1126.07% | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -25.55% | -40.82% | -26.31% | -38.48% | -100.51% | 9.17% | 37.41% | 41.64% | 30.74% | -3.29% | -3.61% | 3.63% |
| Net Income (Continuing) | -26.07M | -17.41M | -11.92M | -12.97M | -20.76M | -12.36M | -9.44M | -9.36M | -10.35M | -13.61M | -15.08M | -16.04M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.20 | -0.16 | -0.12 | -0.20 | -0.31 | -0.20 | -0.14 | -0.14 | -0.21 | -0.41 | -0.35 | -0.37 |
| EPS Growth % | 35.48% | 20% | 14.29% | -42.86% | -47.62% | 51.22% | 60% | 62.16% | 40% | -195.35% | -6.06% | 5.13% |
| EPS (Basic) | -0.20 | -0.16 | -0.12 | -0.20 | -0.31 | -0.20 | -0.14 | -0.14 | -0.21 | -0.41 | -0.35 | -0.37 |
| Diluted Shares Outstanding | 130.29M | 83.88M | 66.38M | 66.38M | 66.29M | 62.21M | 66.19M | 66.17M | 50.16M | 33.48M | 42.97M | 42.94M |
| Basic Shares Outstanding | 130.29M | 83.88M | 66.38M | 66.38M | 66.29M | 62.21M | 66.19M | 66.17M | 50.16M | 33.48M | 42.97M | 42.94M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |